CAS: 59865-16-6; Iso Cyclosporin A

该化合物是一种环球浸泡物,是环球甲醚的衍生物,以其免疫抑制特性而著称,主要特征是独特的环状结构,由11种氨酸组成,在特定序列中相连,有助于其生物活动;Isocylosporin A展示了高度的亲眼病性,影响其溶性,影响其生物膜的可溶性和渗透性;该化合物因其能够抑制T细胞的活化和扩散,使其在移植医学和自动免疫疾病治疗中具有价值而引人注目;该作用机制涉及与环球菌结合,导致抑制Calcileurin,这是T细胞信号路径中的一种关键酶.此外,Isocyloosporin A可能与其母体化合物相比具有不同程度的药用性皮肤病特性,影响其治疗效率和安全性特征.与许多免疫抑制剂一样,谨慎的监测对于管理潜在的副作用至关重要,包括增加感染和器官毒性的敏感度.

结构式图片

上下游产品

cyclosporin A

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-4396542-A
    优先权日:1980-02-14
    标 题 :Method for the total synthesis of cyclosporins, novel cyclosporins and novel intermediates and methods for their production
    发明人:WENGER ROLAND
    权利人:SANDOZ LTD
    摘要:A method for the total synthesis of cyclosporins, in particular Cyclosporin A, cyclosporins produced in accordance with the method of the invention and novel intermediates, in particular novel [1S, 2R, 3R]- and [1R, 2S, 3S]-1-nitrilo-1-carbonyl-3-methyl-2-oxy-heptanes and -hept-5-enes, employed in the method of the invention.

    专利号:US-4554351-A
    优先权日:1980-02-14
    标 题:Method for the total synthesis of cyclosporins, novel cyclosporins and novel intermediates and methods for their production
    发明人:WENGER ROLAND
    权利人:SANDOZ LTD
    摘要:A method for the total synthesis of cyclosporins, in particular Cyclosporin A, cyclosporins produced in accordance with the method of the invention and novel intermediates, in particular novel [1S, 2R, 3R]- and [1R, 2S, 3S]-1-nitrilo-1-carbonyl-3-methyl-2-oxy-heptanes and -hept-5-enes, employed in the method of the invention.

    专利号:CN-1571795-A
    优先权日:2001-10-19
    标 题:Synthesis of Cyclosporine Analogs

    专利号:EP-0034567-B1
    优先权日:1980-02-14
    标 题 :A method for the total synthesis of cyclosporins and novel cyclosporins

    专利号:EP-0098457-B1
    优先权日:1980-02-14
    标 题:(1s,2r,3r)- and (1r,2s,3s)-nitrilo-1-carbonyl-3-methyl-2-oxy-heptanes and -hept-5-enes useful in the total synthesis of cyclosporins and processes for their production

    专利号:IE-54936-B1
    优先权日:1980-02-14
    标 题:A method for the total synthesis of cyclosporins, novel cyclosporins and novel intermediates and methods for their production
    上海昶衍化工科技有限公司
    小微企业
    信用代码: 91310116588693169L法定代表人:杨永宁
    注册资本:50万(元)企业类型:有限责任公司(自然人投资或控股)
    成立日期:2012-01-05登记机关:金山区市场监督管理局
    注册地址: 上海市金山区枫泾镇环东一路65弄2号2107室
    从事化工科技领域内的技术开发、技术服务、技术咨询,化工原料及产品(除危险化学品、监控化学品、烟花爆竹、民用爆炸物品、易制毒化学品),实验室设备,金属材料,包装材料销售,从事货物进出口及技术进出口业务,贸易经纪与代理。
    免费会员展台
    https://www.changyanchem.cn
    企业联系电话:021-2024 2659👤
    上海昶衍化工科技有限公司
    销售经理: 王经理
    手机:18930833303
    客服热线:021-2024 2659
    传真:021-2024 2659
    微信:18930833303
    E-mail:Sales@changyanchem.cn
    QQ: 2314616215
    ⚠️ 声明: 咨询或交易时请注意风险评估和信息核实,百琢研不参与任何交易。

    上海市金山区枫泾镇环东一路65弄2号2107室
    常规和库存产品*产品总量: 1129

    平台资质认证✓营业执照✓
    59865-16-6
    Isocyclosporin A
    其他备注:
    主营化学品定制为主,集药物中间体以及活性分子研发,生产,销售和贸易为一体
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Sanglier JJ, Traber R, Buck RH, Hofmann H, Kobel H. Isolation of (4R)-4-[(E)-2-butenyl]-4-methyl-L-threonine, the characteristic structural element of cyclosporins, from a blocked mutant of Tolypocladium inflatum. J Antibiot (Tokyo). 1990 Jun;43(6):707-14.

    合成参考文献


    参考文献:10.1021/acs.jmedchem.8b01259
    摘要:Naylor MR, Ly AM, Handford MJ, Ramos DP, Pye CR, Furukawa A, Klein VG, Noland RP, Edmondson Q, Turmon AC, Hewitt WM, Schwochert J, Townsend CE, Kelly CN, Blanco MJ, Lokey RS. Lipophilic Permeability Efficiency Reconciles the Opposing Roles of Lipophilicity in Membrane Permeability and Aqueous Solubility. J Med Chem. 2018 Dec 27;61(24):11169–82. doi: 10.1021/acs.jmedchem.8b01259.
    参考文献:10.1021/acs.jmedchem.1c00580
    摘要:Corbett KM, Ford L, Warren DB, Pouton CW, Chalmers DK. Cyclosporin Structure and Permeability: From A to Z and Beyond. J Med Chem. 2021 Sep 23;64(18):13131–51. doi: 10.1021/acs.jmedchem.1c00580.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知